lansoprazole has been researched along with Pulmonary Disease, Chronic Obstructive in 3 studies
Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
Pulmonary Disease, Chronic Obstructive: A disease of chronic diffuse irreversible airflow obstruction. Subcategories of COPD include CHRONIC BRONCHITIS and PULMONARY EMPHYSEMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "One hundred patients with COPD (mean age +/- SD 74." | 2.74 | A randomized, single-blind study of lansoprazole for the prevention of exacerbations of chronic obstructive pulmonary disease in older patients. ( Arai, H; Araya, J; Asamura, T; Kuwano, K; Nakayama, K; Ohrui, T; Sasaki, T; Yamaya, M; Yasuda, H; Yoshida, M, 2009) |
| "Chronic obstructive pulmonary disease (COPD) is a common and progressive disease characterised by chronic cough, airflow limitation and recurrent exacerbations." | 2.66 | Proton pump inhibitors for chronic obstructive pulmonary disease. ( Imai, H; Kikuchi, S; Tajiri, T; Tani, Y; Watanabe, N, 2020) |
| "Patients with COPD in groups C and D in the stable phase were stratified into a group with neither gastroesophageal reflux nor lansoprazole therapy (group A) and a group subjected to oral lansoprazole therapy (group B1 ) and a group not subjected to oral lansoprazole therapy (group B2 )." | 1.43 | A 12-month follow-up study on the preventive effect of oral lansoprazole on acute exacerbation of chronic obstructive pulmonary disease. ( Ding, W; Liu, JM; Xiong, W; Zhang, QS; Zhao, W; Zhao, YF, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Kikuchi, S | 1 |
| Imai, H | 1 |
| Tani, Y | 1 |
| Tajiri, T | 1 |
| Watanabe, N | 1 |
| Xiong, W | 1 |
| Zhang, QS | 1 |
| Zhao, W | 1 |
| Ding, W | 1 |
| Liu, JM | 1 |
| Zhao, YF | 1 |
| Sasaki, T | 1 |
| Nakayama, K | 1 |
| Yasuda, H | 1 |
| Yoshida, M | 1 |
| Asamura, T | 1 |
| Ohrui, T | 1 |
| Arai, H | 1 |
| Araya, J | 1 |
| Kuwano, K | 1 |
| Yamaya, M | 1 |
1 review available for lansoprazole and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Proton pump inhibitors for chronic obstructive pulmonary disease.
Topics: Aged; Disease Progression; Humans; Lansoprazole; Proton Pump Inhibitors; Pulmonary Disease, Chronic | 2020 |
1 trial available for lansoprazole and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
A randomized, single-blind study of lansoprazole for the prevention of exacerbations of chronic obstructive pulmonary disease in older patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Infective Agents; Common Cold; Female; Humans; J | 2009 |
1 other study available for lansoprazole and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
A 12-month follow-up study on the preventive effect of oral lansoprazole on acute exacerbation of chronic obstructive pulmonary disease.
Topics: Acute Disease; Administration, Oral; Aged; Cytokines; Female; Follow-Up Studies; Forced Expiratory V | 2016 |